Press Releases
 
CEA Antibodies Market: Report 2015 and Future Opportunity Assessment 2023

, 20 September 2018 -- CEA Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

CEA stands for carcinoembryonic antigen, is a protein that is usually produced in developing fetus and disappears or is absent in ######. Production of abnormal amount of CEA protein may lead to cancer. CEA test is performed to measure the level of proteins and check for the recurrence of colon and other cancers in patients already diagnosed with cancer. The normal accepted range of this protein that is non-cancerous in nature is 0 micrograms to 0.25 micrograms per liter of blood. Elevated levels of carcinoembryonic antigen in patients recently treated for cancer, indicates recurrence of the cancer.

The elevated levels of carcinoembryonic antigens results in different types of cancers and other conditions such as cholecystitis, lung infection, heavy smoking, inflammatory bowel diseases, peptic and ulcer. High level of carcinoembryonic antigens is also found in the patients who are not diagnosed with cancer. This increases the risk of developing cancer in such patients. Hematoma (blood accumulating under the skin), infection, dizziness and excessive bleeding are some of the risks associated with abnormal levels of CEA. The abnormal levels of CEA in the body can be detected by using arcitumomab, a monoclonal antibody. This is commonly utilized in identification of glycoprotein expression in tissue samples. CEA antibody acts against the CEA, and help treat patients with presence of CEA protein. Hence, this antibody in utilized extensively to treat the patients suffering from CEA associated cancers.

Obtain Report Details @ https://www.transparencymarketresearch.com/cea-antibodies-market.html

Several drugs (CEA antibody) are currently available in the market that are utilized to treat CEA cancer. Pan CEA and clone II-7 are some of the examples of CEA antibody drugs. Discovery of specific antigens and biomarkers propels the growth of carcinoembryonic antigen antibody market. Similarly, continuous technological advancements in the drugs will also augment the growth of carcinoembryonic antigen antibody market. Likewise, rise in geriatric population also supports the growth of carcinoembryonic antigen antibody market. This is due to the fact that this class of population is at higher risk for developing CEA associated cancers. The World Health of Organization has estimated that by 2050, around 2 billion people belong to this population. However, lack of awareness and availability of novel technological solutions might pose a challenge to the growth of CEA antibody market.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4682

In 2012, North America accounted for the largest share of the global carcinoembryonic antigen antibody market. This is due to the presence of large number of companies engaged in developing and manufacturing carcinoembryonic antigen antibodies. Also, increasing R&D expenditure by various players in the region will augment the growth of carcinoembryonic antigen antibody market. Likewise, increasing government initiatives regarding the development of carcinoembryonic antigen antibody will further accentuate the growth of carcinoembryonic antigen antibody market. Europe accounted for the second largest share by revenue in 2012 of global carcinoembryonic antigen antibody market.

This large market revenue is attributed to the presence of large geriatric population coupled with increasing healthcare expenditure in the region. Asia-Pacific along with Rest of the World (RoW) contributed smallest share in the global carcinoembryonic antigen antibody market in 2012. Lack of awareness coupled with presence of few pharmaceutical companies that are engaged in developing and manufacturing carcinoembryonic antigen antibodies restrict the growth of carcinoembryonic antigen antibody market in these two regions of the globe.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=4682

Some of the major players operating in the carcinoembryonic antigen antibody market include Abbott Laboratories, Siemens Healthcare, bioMerieux, Danaher Corporation (Beckman Coulter), Myriad Genetics, Epigenomics, Qiagen N.V., and Life Technologies Corporation among other significant players.

# # #


Submitted by hawer on Thursday, 20 September 2018 at 9:35 PM
Category: Enterprise Technology
 
Related News

Global Data Centre Virtualization Market Revenue, Trend & Regional Forecast By Top Players
Wednesday, 12 Dec 2018

2018 - 2025: Global Data Security Software Market Key Players Such As Symantec and McAfee
Wednesday, 12 Dec 2018

Global Cloud Computing Service Market Booming With Amazon and Salesforce.com
Wednesday, 12 Dec 2018

Cognitive Assessment & Training Market Highly Growing in Global Industry - Cambridge Cognition
Wednesday, 12 Dec 2018

Global Building Energy Management Solutions Market to Witness Huge Growth With Key Players
Wednesday, 12 Dec 2018

Related Events

Palo Alto Networks: PALO ALTO NETWORKS NEXT GENERATION ULTIMATE TEST DRIVE
Thursday, 13 Dec 2018

Palo Alto Networks: CYBER TUESDAY – CYBER SECURITY BEST PRACTICES – LEVEL 1
Tuesday, 18 Dec 2018

Palo Alto Networks: CYBER TUESDAY – CYBER SECURITY BEST PRACTICES – LEVEL 1
Tuesday, 15 Jan 2019

Palo Alto Networks: Palo Alto Networks and Lightstream Roundtable
Wednesday, 16 Jan 2019

Palo Alto Networks: GO FAST, STAY SECURE - Security for Public Clouds
Thursday, 17 Jan 2019

Latest News

How to get the most fuel out of microalgae?
Friday, 14 Dec 2018

How will you tell if you are a movable addict?
Friday, 14 Dec 2018

The Complete Analysis Of A Business With Quickbooks Advanced Reporting
Friday, 14 Dec 2018

Know The Major Factors Involved In IPTV Without Freeze
Friday, 14 Dec 2018

Commercial Bridging Loan - Loans to Move Forward
Friday, 14 Dec 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Friday, 14 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • The Garage Online Challenges for the Future of Energy
  • The Garage Online Challenges For The Future Of Mobility
  • Palo Alto Networks: COORDINATE YOUR ENDPOINT AND NETWORK SECURITY
  • Advances in Inflammatory Bowel Diseases (AIBD) December 13-15, 2018
  • Original Emergency Medicine Boot Camp

  • Latest Jobs
    Sorry, there are currently no entries posted here.